Skip to content

GLP-1 and incretin · compound · regulatory review 2026-10-09

Tirzepatide

GIP and GLP-1 receptor agonist.

The cited evidence and any approval concern the studied or labeled preparation. Oral, nasal, cosmetic and research-market versions do not inherit product approval or proven efficacy.

Editorial review 2026-10-12. source-curated; clinician review pending.

FDA product
approved product
Compounding
not established
Research
product specific
Sport
unknown

What is Tirzepatide?

Other names in the library include Zepbound, Mounjaro, T-10, and T-30. Approved-product evidence applies to the labeled pen in DailyMed. A 10 mg or 30 mg research vial is a seller listing. It is not a substitute pen. It does not let you copy the label schedule.

In plain language

Tirzepatide hits GIP and GLP-1 receptors. Zepbound and Mounjaro are separate FDA-approved products with their own labels. Compounded or research-market tirzepatide does not carry those approvals. This page keeps the label evidence and the research-market listings apart.

What the evidence says

For each trial, check who or what was studied, which preparation was used and what the findings support before comparing it with personal reports about individual experiences or seller listings that describe a product but don’t establish that it works.

Product label

Approved product label

People meeting labeled weight-management or obstructive-sleep-apnea criteria; other approved products have different indications.

Reported findings. In a 72-week randomized trial of 2,539 adults with obesity, or overweight plus a weight-related condition, without type 2 diabetes, estimated average weight loss was 15.0%, 19.5% and 20.9% in the assigned 5, 10 and 15 mg weekly tirzepatide study groups, versus 3.1% with placebo. Doses increased gradually, and all groups received diet and physical-activity support. These are study results, not dosing advice.

Nonresponse. At least 5% weight loss was reached by 85.1%, 88.9% and 90.9% of the respective treatment groups versus 34.5% with placebo. Some participants did not reach that threshold; group averages do not predict an individual result.

Harms. Gastrointestinal reactions, pancreatitis and dehydration-related kidney injury are among label warnings.

Limits. Labeled preparation only; marketed variants do not inherit approval. This result concerns the studied subcutaneous preparation and population; it does not establish equivalence of compounded or research products. Missing week-72 weights were estimated in the analysis. Weight change does not establish a food-noise or personal quality-of-life benefit.

Preparation: Zepbound; Mounjaro is a separate labeled product. Route: subcutaneous

Read original source ↗

Editorial review 2026-10-12. Clinician review pending.

Regulatory status, dated 2026-10-09

FDA product approval

approved product. Zepbound; Mounjaro is a separate labeled product.

Compounding

not established. Compounded products do not carry FDA product approval; legal eligibility is not established here.

Research

product specific. People meeting labeled weight-management or obstructive-sleep-apnea criteria; other approved products have different indications.

Sport

unknown. Not individually verified; consult your sport authority.

How long it lasts, how you store it, listed sizes

This entry doesn’t give a duration in hours. The current Zepbound label reports approximately 5–6 days; no falsely precise single value is supplied.

The vendor file lists 10 mg and 30 mg research sizes. Approved pens have their own storage carton. Keep those instructions separate.

U-100 math for listed Tirzepatide sizes. Each cell is micrograms per syringe mark if you add that much liquid. The table does the same math as the calculator. It does not pick an amount for you.

Micrograms per U-100 unit (100 marks / mL)
Listed vial1 mL liquid2 mL liquid3 mL liquid
10 mg1005033.3
30 mg300150100

Risks and mix-ups already on the record

  • Gastrointestinal reactions, pancreatitis and dehydration-related kidney injury are among label warnings.
  • Personal or family medullary thyroid carcinoma, MEN2, or serious hypersensitivity: see the full product label.
  • Insulin and sulfonylureas can increase hypoglycemia risk; delayed gastric emptying can affect oral medicines.
  • The label warns of reduced oral hormonal contraceptive efficacy; discuss alternative or additional contraception with the prescribing clinician.

People using PepBear often log: Existing clinician-directed records, symptoms and dated health measurements. Record missing data; trends do not demonstrate causation.

Sources

  1. Approved product label · checked 2026-10-09
  2. Zepbound DailyMed label · checked 2026-10-09
  3. SURMOUNT-1 (PubMed 36356202) · checked 2026-10-09
  4. FDA concerns about unapproved GLP-1 drugs · checked 2026-10-09

Questions people ask

Is a research tirzepatide vial the same as Zepbound?

Zepbound is a specific approved product. Research-market vials are not that product. They do not inherit its approval or proven sameness.

Where do the unit numbers come from?

From the mass and liquid you type and a U-100 scale of 100 marks per mL. The page never fills a medical amount.

Related cards

A licensed clinician must interpret the evidence for your situation. This entry provides education, not treatment instructions. Not medical advice. PepBear does not pick a dose, a cycle, or a seller.

Optional merchant comparison

Where to buy Tirzepatide

Compare the same identity, formulation and format. Blends, oral products and different variants stay separate. A lower price does not establish product quality or medical suitability.

We earn a commission when you buy through PepStar LLC partner links or codes RICHPEP and PEPBEAR. Merchant listings are separate from the evidence and do not establish product quality or medical suitability.

Other dated listings with incomplete quantity or equivalence verification (2)

Individual listing · equivalence unverified

Tirzepatide product listings. Prices exclude unverified shipping and tax.
Price / savingsProduct / quantityTerms / availabilityAction
Price unavailableProduct subtotal. Shipping and tax excluded where unverified.Tirzepatide 10mgAscensionFormulation not verified · format not verifiedQuantity not verified. No total mg or price per mg.Listed in stock

50% repeat-use program confirmed. Item eligibility, code and stacking unverified; no coupon included in this price.

Dates and offer terms

Price verified: not verified. Quantity verified: not verified.

Listing observed: Oct 9, 2026. Confirm availability with the seller.

Item terms verified: not verified. Eligibility: unknown. Stacking: unknown.

50% repeat-use coupon program confirmed Oct 9, 2026. Actual code, item exclusions and stacking need confirmation before checkout.

Shipping: not verified; seller charges excluded. Tax: not verified; excluded.

View product: Tirzepatide 10mg at Ascension (opens new tab)Exact merchant listingPartner customer link (opens new tab)Opens the partner referral page. Choose the exact product there; this is separate from the listing above.
Listing source

listing · Oct 9, 2026

Individual listing · equivalence unverified

Tirzepatide product listings. Prices exclude unverified shipping and tax.
Price / savingsProduct / quantityTerms / availabilityAction
Price unavailableProduct subtotal. Shipping and tax excluded where unverified.Tirzepatide 30mgAscensionFormulation not verified · format not verifiedQuantity not verified. No total mg or price per mg.Listed in stock

50% repeat-use program confirmed. Item eligibility, code and stacking unverified; no coupon included in this price.

Dates and offer terms

Price verified: not verified. Quantity verified: not verified.

Listing observed: Oct 9, 2026. Confirm availability with the seller.

Item terms verified: not verified. Eligibility: unknown. Stacking: unknown.

50% repeat-use coupon program confirmed Oct 9, 2026. Actual code, item exclusions and stacking need confirmation before checkout.

Shipping: not verified; seller charges excluded. Tax: not verified; excluded.

View product: Tirzepatide 30mg at Ascension (opens new tab)Exact merchant listingPartner customer link (opens new tab)Opens the partner referral page. Choose the exact product there; this is separate from the listing above.
Listing source

listing · Oct 9, 2026